Literature DB >> 16267043

Deregulation of proteasome function induces Abl-mediated cell death by uncoupling p130CAS and c-CrkII.

Monica Holcomb1, Alessandra Rufini, Daniela Barilà, Richard L Klemke.   

Abstract

Cell migration and survival are coordinately regulated through activation of c-Abl (Abl) family tyrosine kinases. Activated Abl phosphorylates tyrosine 221 of c-CrkII (Crk; Crk-Y221-P), which prevents Crk from binding to the docking protein p130(CAS) (CAS). Disruption of CAS-Crk binding blocks downstream effectors of the actin cytoskeleton and focal adhesion assembly, inhibits cell migration, and disrupts survival signals leading to apoptosis. Here we show that inhibition of the 26 S proteasome and ubiquitination facilitates Abl-mediated Crk-Y221-P, leading to disassembly of CAS-Crk complexes in cells. Surprisingly, inhibition of these molecular interactions does not perturb cell migration but rather specifically induces apoptosis. Furthermore, we demonstrate that attachment to an extracellular matrix plays a key role in regulating the apoptotic machinery through caspase-mediated cleavage of Abl and Crk-Y221-P. Our findings indicate that regulated protein degradation by the proteasome specifically controls cell death through regulation of Abl-mediated Crk Tyr221 phosphorylation and assembly of the CAS-Crk signaling scaffold.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267043     DOI: 10.1074/jbc.M508454200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected].

Authors:  Yingchun Wang; Jonathan A Kelber; Hop S Tran Cao; Greg T Cantin; Rui Lin; Wei Wang; Sharmeela Kaushal; Jeanne M Bristow; Thomas S Edgington; Robert M Hoffman; Michael Bouvet; John R Yates; Richard L Klemke
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  The Abl-1 Kinase is Dispensable for NK Cell Inhibitory Signalling and is not Involved in Murine NK Cell Education.

Authors:  S Ganesan; T T Luu; B J Chambers; S Meinke; P Brodin; E Vivier; D M Wetzel; A J Koleske; N Kadri; P Höglund
Journal:  Scand J Immunol       Date:  2017-09       Impact factor: 3.487

Review 3.  Integrin signalling adaptors: not only figurants in the cancer story.

Authors:  Sara Cabodi; Maria del Pilar Camacho-Leal; Paola Di Stefano; Paola Defilippi
Journal:  Nat Rev Cancer       Date:  2010-11-24       Impact factor: 60.716

4.  The adaptor proteins p140CAP and p130CAS as molecular hubs in cell migration and invasion of cancer cells.

Authors:  Paola Di Stefano; Maria Pilar Camacho Leal; Giusy Tornillo; Brigitte Bisaro; Daniele Repetto; Alessandra Pincini; Emanuela Santopietro; Nanaocha Sharma; Emilia Turco; Sara Cabodi; Paola Defilippi
Journal:  Am J Cancer Res       Date:  2011-05-02       Impact factor: 6.166

5.  c-Abl mediates endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 and by disruption of actin.

Authors:  Jingying Xu; Melissa Millard; Xiuhai Ren; Orla T Cox; Anat Erdreich-Epstein
Journal:  Blood       Date:  2010-02-02       Impact factor: 22.113

6.  Src, p130Cas, and Mechanotransduction in Cancer Cells.

Authors:  Hiroyuki Matsui; Ichiro Harada; Yasuhiro Sawada
Journal:  Genes Cancer       Date:  2012-05

7.  Dynamic phosphorylation of tyrosine 665 in pseudopodium-enriched atypical kinase 1 (PEAK1) is essential for the regulation of cell migration and focal adhesion turnover.

Authors:  Jeanne M Bristow; Theresa A Reno; Minji Jo; Steven L Gonias; Richard L Klemke
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

8.  Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk.

Authors:  Mary E Peterson; Eric O Long
Journal:  Immunity       Date:  2008-10-02       Impact factor: 31.745

9.  A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.

Authors:  Ly Tu; Frances S De Man; Barbara Girerd; Alice Huertas; Marie-Camille Chaumais; Florence Lecerf; Charlène François; Frédéric Perros; Peter Dorfmüller; Elie Fadel; David Montani; Saadia Eddahibi; Marc Humbert; Christophe Guignabert
Journal:  Am J Respir Crit Care Med       Date:  2012-07-12       Impact factor: 21.405

10.  Neuroprotective efficacy of a new brain-penetrating C-Abl inhibitor in a murine Parkinson's disease model.

Authors:  Syed Z Imam; William Trickler; Shinya Kimura; Zbigniew K Binienda; Merle G Paule; William Slikker; Senlin Li; Robert A Clark; Syed F Ali
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.